The effects of l,l-dimethyl-4-phenyl-piperazinium (DMPP) in the cat superior cervical ganglion in situ.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D002586:Cesium / Q000494:pharmacology; D003714:Denervation; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004558:Electric Stimulation; D004566:Electrodes; D005727:Ganglia, Spinal / Q000187:drug effects*; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008464:Mecamylamine / Q000494:pharmacology; D008698:Mesylates / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D005731:Ganglionic Stimulants; D006584:Hexamethonium Compounds; D008698:Mesylates; D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D000804:Angiotensin II; D002586:Cesium; D012701:Serotonin; D004246:Dimethylphenylpiperazinium Iodide; D010042:Ouabain; D008464:Mecamylamine; D001285:Atropine; D012601:Scopolamine; D007545:Isoproterenol; D000109:Acetylcholine; D001920:Bradykinin; D014403:Tubocurarine